Acorah Software Products - Accounts Production15.0.600falsetruefalsetrueNo description of principal activity28 November 202230 November 202330 November 202314510237Mr Emmanuel Adesuyiiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure145102372022-11-27145102372023-11-30145102372022-11-282023-11-3014510237frs-core:CurrentFinancialInstruments2023-11-3014510237frs-bus:PrivateLimitedCompanyLtd2022-11-282023-11-3014510237frs-bus:FilletedAccounts2022-11-282023-11-3014510237frs-bus:Micro-entities2022-11-282023-11-3014510237frs-bus:AuditExempt-NoAccountantsReport2022-11-282023-11-3014510237frs-bus:Director12022-11-282023-11-30
Registered number: 14510237
Cyrusunik Research Team Ltd
Unaudited Financial Statements
For The Year Ended 30 November 2023
Cyrusunik Research Team Ltd
Balance Sheet
As At 30 November 2023
Balance Sheet
Registered number: 14510237
2023
£
Current assets
477
Creditors: Amounts Falling Due Within One Year
(235)
NET CURRENT ASSETS
242
TOTAL ASSETS LESS CURRENT LIABILITIES
242
Accruals and deferred income
(240)
NET ASSETS
2
CAPITAL AND RESERVES
2
Notes
1.General Information
Cyrusunik Research Team Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14510237. The registered office is 10 Charles Wayte Drive, Crewe, Cheshire, CW1 3US.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.